Marc Schegerin - 14 Jun 2023 Form 4 Insider Report for SQZ Biotechnologies Co (SQZB)

Role
Director
Signature
/s/ Lawrence Knopf as Attorney in Fact for Marc Schegerin
Issuer symbol
SQZB
Transactions as of
14 Jun 2023
Transactions value $
$0
Form type
4
Filing time
15 Jun 2023, 16:45:06 UTC
Previous filing
27 Apr 2023
Next filing
08 Sep 2023
SEC
View on sec.gov

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction SQZB Common Stock Award $0 +39.9K $0.00 39.9K 14 Jun 2023 Common Stock 39.9K $0.54 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The option vests and become exercisable on the earlier of (i) June 14, 2024 or (ii) the day immediately prior to the date of the next annual meeting of stockholders following the date of grant, in each case subject to the recipient's continued service on the Board at such time.